$TBTC
TABLE TRAC INC Stock $tbtc

$tbtc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015971 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.456M	$2.021M	$2.302M
YoY Change	41.85%	-12.23%	-31.31%
Cost Of Revenue	$997.6K	$544.2K	$421.8K
YoY Change	76.1%	29.01%	-36.24%
Gross Profit	$2.459M	$1.477M	$1.881M
YoY Change	31.47%	-21.48%	-30.1%
Gross Profit Margin	71.14%	73.07%	81.68%
Selling, General & Admin	$1.490M	$1.489M	$1.544M
YoY Change	23.99%	-3.55%	42.1%
% of Gross Profit	60.6%	100.84%	82.09%
Research & Development	$16.77K	$17.43K	$16.28K
YoY Change	3.01%	7.1%
% of Gross Profit	0.68%	1.18%	0.87%
Depreciation & Amortization	$3.510K	$3.110K	$0.00
YoY Change			-100.0%
% of Gross Profit	0.14%	0.21%	0.0%
Operating Expenses	$1.490M	$1.506M	$1.560M
YoY Change	23.99%	-3.44%	43.6%
Operating Profit	$968.8K	-$12.43K	$336.8K
YoY Change	44.91%	-103.69%	-79.0%
Interest Expense	$91.80K	$86.08K	$88.48K
YoY Change	9.09%	-2.71%	116.28%
% of Operating Profit	9.48%		26.27%
Other Income/Expense, Net	$0.00	$1.010K	$0.00
YoY Change	-100.0%		-100.0%
Pretax Income	$1.061M	$74.66K	$425.3K
YoY Change	40.11%	-82.44%	-74.31%
Income Tax	$254.0K	$63.00K	$89.40K
% Of Pretax Income	23.95%	84.38%	21.02%
Net Earnings	$806.6K	$11.66K	$335.9K
YoY Change	41.16%	-96.53%	-73.38%
Net Earnings / Revenue	23.34%	0.58%	14.59%
Basic Earnings Per Share	$0.18	$0.00	$0.07
Diluted Earnings Per Share	$0.17	$0.00	$0.07
COMMON SHARES
Basic Shares Outstanding	4.654M	4.635M	4.622M
Diluted Shares Outstanding	4.627M	4.601M	4.627M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.117M	$6.085M	$5.282M
YoY Change	28.66%	15.19%	-7.32%
Cash & Equivalents	$2.478M	$4.497M	$5.219M
Short-Term Investments	$3.639M	$1.588M	$63.49K
Other Short-Term Assets	$610.3K	$547.5K	$453.9K
YoY Change	-19.03%	20.61%	-55.2%
Inventory	$2.314M	$2.837M	$1.724M
Prepaid Expenses	$610.3K	$547.5K	$453.9K
Receivables	$1.797M	$1.350M	$1.769M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.84M	$10.82M	$9.229M
YoY Change	16.34%	17.23%	-0.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.10K	$54.65K	$143.3K
YoY Change	-53.3%	-61.86%	2808.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$80.77K	$97.32K	$161.1K
YoY Change	-45.86%	-39.59%	26.72%
Other Assets
YoY Change
Total Long-Term Assets	$2.174M	$1.065M	$1.399M
YoY Change	49.1%	-23.91%	40.25%
TOTAL ASSETS
Total Short-Term Assets	$10.84M	$10.82M	$9.229M
Total Long-Term Assets	$2.174M	$1.065M	$1.399M
Total Assets	$13.01M	$11.88M	$10.63M
YoY Change	20.77%	11.81%	3.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$260.8K	$361.7K	$429.4K
YoY Change	39.94%	-15.79%	122.37%
Accrued Expenses	$61.39K	$116.8K	$107.3K
YoY Change	-50.08%	8.94%	79.44%
Deferred Revenue	$1.057M	$849.6K	$1.078M
YoY Change	50.64%	-21.16%	-17.7%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.393M	$1.728M	$1.623M
YoY Change	37.79%	6.52%	-30.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$470.8K	$96.67K	$81.18K
YoY Change	625.49%	19.08%	-27.74%
Total Long-Term Liabilities	$470.8K	$96.67K	$81.18K
YoY Change	625.49%	19.08%	-27.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.393M	$1.728M	$1.623M
Total Long-Term Liabilities	$470.8K	$96.67K	$81.18K
Total Liabilities	$2.290M	$1.994M	$1.992M
YoY Change	44.57%	0.11%	-20.19%
SHAREHOLDERS EQUITY
Retained Earnings	$8.544M	$7.737M	$6.634M
YoY Change	19.35%	16.63%	10.01%
Common Stock	$2.402M	$2.376M	$2.229M
YoY Change	6.43%	6.59%	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.72M	$9.890M	$8.637M
YoY Change
Total Liabilities & Shareholders Equity	$13.01M	$11.88M	$10.63M
YoY Change	20.77%	11.81%	3.2%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$806.6K	$11.66K	$335.9K
YoY Change	41.16%	-96.53%	-73.38%
Depreciation, Depletion And Amortization	$3.510K	$3.110K	$0.00
YoY Change			-100.0%
Cash From Operating Activities	$35.41K	$1.026M	$432.0K
YoY Change	-107.34%	137.41%	-39.48%
INVESTING ACTIVITIES
Capital Expenditures	$8.120K	$18.57K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.000M
YoY Change
Cash From Investing Activities	-$2.008M	-$18.57K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-46.35K
YoY Change	6.99%
NET CHANGE
Cash From Operating Activities	35.41K	$1.026M	$432.0K
Cash From Investing Activities	-2.008M	-$18.57K	$0.00
Cash From Financing Activities	-46.35K
Net Change In Cash	-2.019M	$1.007M	$432.0K
YoY Change	284.2%	133.11%	-39.48%
FREE CASH FLOW
Cash From Operating Activities	$35.41K	$1.026M	$432.0K
Capital Expenditures	$8.120K	$18.57K	$0.00
Free Cash Flow	$27.29K	$1.007M	$432.0K
YoY Change		133.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4756734
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4756734
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4634865
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4634865
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	121869
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	121869
CY2024Q1	tbtc	Number Of Certificates Of Deposit NumberOfCertificatesOfDeposit	1	pure
CY2024Q1	tbtc	Certificates Of Deposit Term CertificatesOfDepositTerm	P7M
CY2023Q1	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	0	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-32987
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0336568
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6101 Baker Road, Suite 206
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Minnetonka
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55345
CY2024Q1	dei	City Area Code CityAreaCode	952
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	548-8877
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4654365
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4496840	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3489771	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	1522654	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	1502805	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1350301	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2109193	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2836837	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2904158	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	547475	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	364886	usd
CY2024Q1	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent	65280	usd
CY2023Q4	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent	64310	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	10819387	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	10435123	usd
CY2024Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	681480	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	891351	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54652	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38357	usd
CY2024Q1	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent	97319	usd
CY2023Q4	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent	113621	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	15857	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	16691	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	215421	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	243171	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1064729	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1303191	usd
CY2024Q1	us-gaap	Assets Assets	11884116	usd
CY2023Q4	us-gaap	Assets Assets	11738314	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	361648	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	305664	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	849630	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	785805	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	116842	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114294	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	400226	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	165226	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1728346	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1370989	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96668	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	126760	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	169000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	341000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1994014	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1838749	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4635	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4635	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2371706	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2346483	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7736969	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7771655	usd
CY2024Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	10113310	usd
CY2023Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	10122773	usd
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	223208	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	223208	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9890102	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9899565	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11884116	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11738314	usd
CY2024Q1	us-gaap	Revenues Revenues	2020795	usd
CY2023Q1	us-gaap	Revenues Revenues	2302410	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	544201	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	421841	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1476594	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1880569	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1489022	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1543786	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12428	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	336783	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1006	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	86083	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	88478	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74661	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	425261	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11661	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	335861	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4574365
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4551988
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4601471
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4626930
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8275692	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	25224	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	335861	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8636777	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9899565	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	25223	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	46347	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11661	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9890102	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	11661	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	335861	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3105	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-172000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-43000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-16723	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25223	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25224	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	19849	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-985485	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-528445	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-67321	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	163814	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	182589	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36658	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-15332	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-11041	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9843	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10056	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	40387	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	63825	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-407924	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-235000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-132400	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1025634	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	432017	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18565	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18565	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1007069	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	432017	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3489771	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4786923	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4496840	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5218940	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	7542	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	46347	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0	usd
CY2024Q1	us-gaap	Revenues Revenues	2020795	usd
CY2023Q1	us-gaap	Revenues Revenues	2302410	usd
CY2024Q1	tbtc	Percent Of Revenues PercentOfRevenues	1	pure
CY2023Q1	tbtc	Percent Of Revenues PercentOfRevenues	1	pure
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	26875	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	22800	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s use of estimates and assumptions include: for revenue recognition, determining collectibility, the nature and timing of satisfaction of performance obligations, and determining the standalone selling price (“SSP”) of performance obligations, realizability of accounts receivable, and the valuation of allowance for credit losses, deferred tax assets and liabilities, and inventory. Actual results could differ from those estimates, and the difference could be significant. For further information about our critical accounting estimates, see the discussion in Item <em style="font: inherit;">7,</em> “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” under the heading “Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2023.</em></span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">There were <em style="font: inherit;">no</em> changes in critical accounting estimates or assumptions for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2024</em>.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The Company’s significant accounting policies are described in Note <em style="font: inherit;">1</em> of the financial statement included in its Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"></p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; "><span style="background-color:#ffffff;">Concentrations of Risk</span></span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company maintains its cash balances at <em style="font: inherit;">two</em> financial institutions. Accounts are insured by the Federal Deposit Insurance Corporation (FDIC) up to <em style="font: inherit;">$250,000</em></span><span style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;">. At times throughout the year, </span></span><span style="background-color:#ffffff;">the Company’s cash balances exceeded amounts insured by the FDIC. The Company doesn’t believe it is exposed to any significant credit risk on its cash balances. Cash equivalents represent money market funds or short-term investments with original maturities of <em style="font: inherit;">three</em> months or less from the date of purchase.</span></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="margin: 0pt; text-align: left; font-size: 10pt; font-family: "Times New Roman", Times, serif;"></p>
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	3392281	usd
CY2024Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	2275285	usd
CY2023Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	2392560	usd
CY2024Q1	tbtc	Certificates Of Deposit Interest Rate CertificatesOfDepositInterestRate	0.0525	pure
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	1522654	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8752	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8768	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2836837	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2904158	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	447897	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	117218	usd
CY2024Q1	us-gaap	Supplies Supplies	68090	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17430	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16275	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	0	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1402198	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2177813	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51897	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	68620	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1350301	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2109193	usd
CY2024Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	681480	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	891351	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	68620	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	62000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-16723	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	15430	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	51897	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	77430	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear	53775	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	71700	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	64700	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	87250
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.36
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	50450	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	175150	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	12551	usd
CY2024Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	162599	usd
CY2024Q1	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent	65280	usd
CY2023Q4	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent	64310	usd
CY2024Q1	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent	97319	usd
CY2023Q4	tbtc	Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent	113621	usd
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0825	pure
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	27750	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	14508	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	91557	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	95030	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	40496	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	227083	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13573	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	213510	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.01
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000
CY2021Q2	tbtc	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	128726	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16500
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	37969	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	19500
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	38331	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	60500
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	80000
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	218430	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	319000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99750
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M23D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.25
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	119750
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	101500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.97
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99750
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	101500
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.97
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	87250
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.36
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	76500
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.15
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11661	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	335861	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4574365
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4551988
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4601471
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4626930
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	27106
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	74942

Files In Submission

Name	View Source	Status
0001437749-24-015971-index-headers.html	Edgar Link	pending
0001437749-24-015971-index.html	Edgar Link	pending
0001437749-24-015971.txt	Edgar Link	pending
0001437749-24-015971-xbrl.zip	Edgar Link	pending
ex_650071.htm	Edgar Link	pending
ex_650072.htm	Edgar Link	pending
ex_650073.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tbltrc20240331_10q.htm	Edgar Link	pending
tbtc-20240331.xsd	Edgar Link	pending
tbtc-20240331_def.xml	Edgar Link	unprocessable
tbtc-20240331_lab.xml	Edgar Link	unprocessable
tbtc-20240331_pre.xml	Edgar Link	unprocessable
tbltrc20240331_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tbtc-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TBTC
TABLE TRAC INC Stock $tbtc

2024 Q2 Form 10-Q Financial Statement

#000143774924015971 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBTC TABLE TRAC INC Stock $tbtc

2024 Q2 Form 10-Q Financial Statement

#000143774924015971 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TBTC
TABLE TRAC INC Stock $tbtc